How has been the historical performance of Novartis India?

Answer:The historical performance of Novartis India shows a fluctuating trend in net sales and profits over the years, with a notable recovery in recent periods.

Breakdown:
Novartis India's net sales have seen a decline from INR 490.68 crore in March 2019 to INR 356.27 crore in March 2025, with a peak of INR 399.87 crore in March 2022. Total operating income followed a similar pattern, decreasing from INR 490.68 crore in March 2019 to INR 356.27 crore in March 2025. The total expenditure, excluding depreciation, also decreased from INR 478.40 crore in March 2019 to INR 264.85 crore in March 2025, contributing to an increase in operating profit, which rose from INR 12.28 crore in March 2019 to INR 133.38 crore in March 2025. Profit before tax improved significantly, reaching INR 130.42 crore in March 2025, compared to a loss of INR 3.82 crore in March 2022. The profit after tax also showed a recovery, increasing to INR 100.90 crore in March 2025 from a loss of INR 3.72 crore in March 2022. The company's cash flow from operating activities improved to INR 74 crore in March 2025, while total assets slightly decreased from INR 1,052.90 crore in March 2020 to INR 932.33 crore in March 2025. Overall, Novartis India has demonstrated resilience with a recovery in profitability and cash flow, despite a downward trend in sales and total assets over the years.